Primecap Management CO Allogene Therapeutics, Inc. Transaction History
Primecap Management CO
- $127 Billion
- Q4 2024
A detailed history of Primecap Management CO transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Primecap Management CO holds 4,927,340 shares of ALLO stock, worth $9.95 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,927,340
Previous 5,668,260
13.07%
Holding current value
$9.95 Million
Previous $15.9 Million
33.87%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding ALLO
# of Institutions
177Shares Held
139MCall Options Held
75.8KPut Options Held
52.8K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$37.8 Million1.1% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$33.2 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR10.9MShares$22 Million9.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8MShares$16.2 Million0.0% of portfolio
-
State Street Corp Boston, MA7.25MShares$14.6 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $290M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...